| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $421.5M | +11.8% |
| Cost of Revenue | $380.0M | +21.3% |
| R&D Expense | $511.4M | +26.2% |
| SG&A Expense | $511.0M | +1.9% |
| Interest Expense | $789.3M | +317.0% |
| Pre-tax Income | -$301.2M | +5.5% |
| Income Tax | -$416K | -124.7% |
| Net Income | -$300.7M | +6.1% |
| EPS (Basic) | -$0.36 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.09B | +117.0% |
| Total Assets | $30.07B | +58.2% |
| Total Liabilities | $24.52B | +81.9% |
| Stockholders' Equity | $5.23B | +0.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.23B | +0.4% |
| Investing Cash Flow | -$1.89B | -1677.3% |
| Financing Cash Flow | $10.89B | +29.0% |
| +10.0% |
| EPS (Diluted) | -$0.36 | +10.0% |